BMA House, Tavistock Square, London, WC1H 9JP

The programme is designed to combine high calibre lectures and interactive discussions to provide an educational opportunity to update clinicians in current issues within the management of Myeloproliferative Neoplasms. Suitable for Consultants, Trainees, Nurses, Pharmacists and Scientists working in Haematology.

Topics to include:

● Prognosis in MPN

● Novel molecular tests
● Stroke and TIA in MPN
● Novel data regarding pathogenesis of MPN
● Aetiology of thrombosis and prevention in MPN
● SVT- what the haematologists need to know 
● Use of novel anticoagulants in MPN or difficult scenarios
● Fertility, pregnancy, IVF
● BCSH Guideline for Eosinophilia
● Systemic mastocytosis
● Treatment free remission in CML 
● Novel agents for MPN
● Myelofibrosis









IPSS-R MDS Risk Assessment Calculator

Revised International Prognostic Scoring System (IPSS-R) for Myelodysplastic Syndromes Risk Assessment Calculator


Click here

MDS Fact Sheet

MDS Factsheet for GPs General Practicioners

MDS Fact Sheet

Click here

Varicella Vaccine in MDS

Urgent Clarification on varicella vaccine policy

Current advice from the UK MDS Forum is not to give the Live Varicella Vaccine to patients with MDS.

Please read below correspondence between Professor Salisbury and Dr George Follows, the latter on behalf of the CLL Forum, on the varicella vaccine policy.
This is an external link to the British Society for Haematology  Click here

NICE Guideline

Lenalidomide for treating myelodysplastic syndromes (MDS) associated with an isolated deletion 5q cytogenetic abnormality.

NICE logo

Click here

BSH Guidelines

This is an external link to the home of the British Society for Haematology (BSH). 

BSH Logo Strapline RGB

Click here